Realising the true benefits of risk management with Brian Barnes

In this episode of Clinical Data Talks, Sylvain Berthelot welcomes Brian Barnes, Director of Risk Management Strategy at BioNTech, to explore the human and strategic dimensions of risk-based quality management (RBQM).

Drawing from his rich experience across CROs, technology vendors, and now a sponsor organisation, Brian shares how his role as a “risk assessment facilitator” reflects a broader cultural shift: developing a company-wide risk-focused mindset and moving risk management upstream into study design and operational planning.

Sylvain and Brian talk about building risk frameworks from the ground up, demonstrating return on investment for RBQM and confronting resistance and misconceptions. Brian offers practical insight into why RBQM is less about the tools and more about people, collaboration, and culture.

Tune in to discover what “good” risk management looks like and how to make it stick – across teams, trials, and organisations.

Share via

See CRScube in action

Book a demo

Explore how our platform will elevate your team and clinical trial management.

Get insights straight to your inbox

Explore our knowledge base

Stay in-the-know with regular updates and industry opinions from our expert team.

See all resources

Featured resources

A discussion with Stanley Kim and Rob Robertson

Although both CRScube and Mednet were built in different environments, there is a strong sense of culture and belonging at their core.

Beyond the data: Human stories from clinical trials in Ukraine

From halting patient recruitment and struggling with the shipment of investigational medicines, to relocating vulnerable oncology patients across borders, Anna paints a vivid picture of resilience and resourcefulness under pressure.

Why Mednet. Why Now.

CRScube and Mednet are a natural fit. We are both innovators in eClinical technology. We both operate on a SaaS model, serve the same customers, and believe in transforming clinical trials.